Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 12 entries
Sorted by: Best Match Show Resources per page
Bioabsorbable Bypass Grafts Biofunctionalised with RGD Have Enhanced Biophysical Properties and Endothelialisation Tested In vivo.

Frontiers in pharmacology

Antonova LV, Seifalian AM, Kutikhin AG, Sevostyanova VV, Krivkina EO, Mironov AV, Burago AY, Velikanova EA, Matveeva VG, Glushkova TV, Sergeeva EA, Vasyukov GY, Kudryavtseva YA, Barbarash OL, Barbarash LS.
PMID: 27252652
Front Pharmacol. 2016 May 25;7:136. doi: 10.3389/fphar.2016.00136. eCollection 2016.

Small diameter arterial bypass grafts are considered as unmet clinical need since the current grafts have poor patency of 25% within 5 years. We have developed a 3D scaffold manufactured from natural and synthetic biodegradable polymers, poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) and...

Cite
Antonova LV, Seifalian AM, Kutikhin AG, et al. Bioabsorbable Bypass Grafts Biofunctionalised with RGD Have Enhanced Biophysical Properties and Endothelialisation Tested In vivo. Front Pharmacol. 2016;7:136doi: 10.3389/fphar.2016.00136.
Antonova, L. V., Seifalian, A. M., Kutikhin, A. G., Sevostyanova, V. V., Krivkina, E. O., Mironov, A. V., Burago, A. Y., Velikanova, E. A., Matveeva, V. G., Glushkova, T. V., Sergeeva, E. A., Vasyukov, G. Y., Kudryavtseva, Y. A., Barbarash, O. L., & Barbarash, L. S. (2016). Bioabsorbable Bypass Grafts Biofunctionalised with RGD Have Enhanced Biophysical Properties and Endothelialisation Tested In vivo. Frontiers in pharmacology, 7136. https://doi.org/10.3389/fphar.2016.00136
Antonova, Larisa V, et al. "Bioabsorbable Bypass Grafts Biofunctionalised with RGD Have Enhanced Biophysical Properties and Endothelialisation Tested In vivo." Frontiers in pharmacology vol. 7 (2016): 136. doi: https://doi.org/10.3389/fphar.2016.00136
Antonova LV, Seifalian AM, Kutikhin AG, Sevostyanova VV, Krivkina EO, Mironov AV, Burago AY, Velikanova EA, Matveeva VG, Glushkova TV, Sergeeva EA, Vasyukov GY, Kudryavtseva YA, Barbarash OL, Barbarash LS. Bioabsorbable Bypass Grafts Biofunctionalised with RGD Have Enhanced Biophysical Properties and Endothelialisation Tested In vivo. Front Pharmacol. 2016 May 25;7:136. doi: 10.3389/fphar.2016.00136. eCollection 2016. PMID: 27252652; PMCID: PMC4879758.
Copy Download .nbib Format: NLM
[A facile method for producing selenocysteine-containing proteins].

Angewandte Chemie (Weinheim an der Bergstrasse, Germany)

Mukai T, Sevostyanova A, Suzuki T, Fu X, Söll D.
PMID: 30002564
Angew Chem Weinheim Bergstr Ger. 2018 Jun 11;130(24):7333-7337. Epub 2018 Apr 06.

No abstract available.

Cite
Mukai T, Sevostyanova A, Suzuki T, et al. Eine einfache Methode zur Produktion von Selenoproteinen. [A facile method for producing selenocysteine-containing proteins]. Angew Chem Weinheim Bergstr Ger. 2018;130(24):7333-7337
Mukai, T., Sevostyanova, A., Suzuki, T., Fu, X., & Söll, D. (2018). Eine einfache Methode zur Produktion von Selenoproteinen. [A facile method for producing selenocysteine-containing proteins]. Angewandte Chemie (Weinheim an der Bergstrasse, Germany), 130(24), 7333-7337.
Mukai, Takahito, et al. "Eine einfache Methode zur Produktion von Selenoproteinen." [A facile method for producing selenocysteine-containing proteins]. Angewandte Chemie (Weinheim an der Bergstrasse, Germany) vol. 130,24 (2018): 7333-7337.
Mukai T, Sevostyanova A, Suzuki T, Fu X, Söll D. Eine einfache Methode zur Produktion von Selenoproteinen. [A facile method for producing selenocysteine-containing proteins]. Angew Chem Weinheim Bergstr Ger. 2018 Jun 11;130(24):7333-7337. Epub 2018 Apr 06. German. PMID: 30002564; PMCID: PMC6039127.
Copy Download .nbib Format: NLM
A Technology for Anti-Thrombogenic Drug Coating of Small-Diameter Biodegradable Vascular Prostheses.

Sovremennye tekhnologii v meditsine

Antonova LV, Krivkina EO, Rezvova MA, Sevostyanova VV, Tkachenko VO, Glushkova TV, Akentyeva TN, Kudryavtseva YA, Barbarash LS.
PMID: 34796013
Sovrem Tekhnologii Med. 2021;12(6):6-12. doi: 10.17691/stm2020.12.6.01. Epub 2020 Dec 28.

MATERIALS AND METHODS: Vascular prostheses from polyhydroxybutyrate/valerate and polycaprolactone with the incorporated vascular endothelial growth factor, the main fibroblast growth factor, and the chemoattractant SDF-1α were made by emulsion electrospinning. Additional surface modification of the prostheses was carried out...

Cite
Antonova LV, Krivkina EO, Rezvova MA, et al. A Technology for Anti-Thrombogenic Drug Coating of Small-Diameter Biodegradable Vascular Prostheses. Sovrem Tekhnologii Med. 2020;12(6):6-12doi: 10.17691/stm2020.12.6.01.
Antonova, L. V., Krivkina, E. O., Rezvova, M. A., Sevostyanova, V. V., Tkachenko, V. O., Glushkova, T. V., Akentyeva, T. N., Kudryavtseva, Y. A., & Barbarash, L. S. (2021). A Technology for Anti-Thrombogenic Drug Coating of Small-Diameter Biodegradable Vascular Prostheses. Sovremennye tekhnologii v meditsine, 12(6), 6-12. https://doi.org/10.17691/stm2020.12.6.01
Antonova, L V, et al. "A Technology for Anti-Thrombogenic Drug Coating of Small-Diameter Biodegradable Vascular Prostheses." Sovremennye tekhnologii v meditsine vol. 12,6 (2021): 6-12. doi: https://doi.org/10.17691/stm2020.12.6.01
Antonova LV, Krivkina EO, Rezvova MA, Sevostyanova VV, Tkachenko VO, Glushkova TV, Akentyeva TN, Kudryavtseva YA, Barbarash LS. A Technology for Anti-Thrombogenic Drug Coating of Small-Diameter Biodegradable Vascular Prostheses. Sovrem Tekhnologii Med. 2021;12(6):6-12. doi: 10.17691/stm2020.12.6.01. Epub 2020 Dec 28. PMID: 34796013; PMCID: PMC8596239.
Copy Download .nbib Format: NLM
bFGF and SDF-1α Improve In Vivo Performance of VEGF-Incorporating Small-Diameter Vascular Grafts.

Pharmaceuticals (Basel, Switzerland)

Antonova L, Kutikhin A, Sevostianova V, Velikanova E, Matveeva V, Glushkova T, Mironov A, Krivkina E, Shabaev A, Senokosova E, Barbarash L.
PMID: 33800631
Pharmaceuticals (Basel). 2021 Mar 28;14(4). doi: 10.3390/ph14040302.

Tissue-engineered vascular grafts are widely tested as a promising substitute for both arterial bypass and replacement surgery. We previously demonstrated that incorporation of VEGF into electrospun tubular scaffolds from poly(3-hydroxybutyrate-co-3-hydroxyvalerate)/poly(ε-caprolactone) enhances formation of an endothelial cell monolayer. However, an...

Cite
Antonova L, Kutikhin A, Sevostianova V, et al. bFGF and SDF-1α Improve In Vivo Performance of VEGF-Incorporating Small-Diameter Vascular Grafts. Pharmaceuticals (Basel). 2021;14(4)doi: 10.3390/ph14040302.
Antonova, L., Kutikhin, A., Sevostianova, V., Velikanova, E., Matveeva, V., Glushkova, T., Mironov, A., Krivkina, E., Shabaev, A., Senokosova, E., & Barbarash, L. (2021). bFGF and SDF-1α Improve In Vivo Performance of VEGF-Incorporating Small-Diameter Vascular Grafts. Pharmaceuticals (Basel, Switzerland), 14(4), . https://doi.org/10.3390/ph14040302
Antonova, Larisa, et al. "bFGF and SDF-1α Improve In Vivo Performance of VEGF-Incorporating Small-Diameter Vascular Grafts." Pharmaceuticals (Basel, Switzerland) vol. 14,4 (2021). doi: https://doi.org/10.3390/ph14040302
Antonova L, Kutikhin A, Sevostianova V, Velikanova E, Matveeva V, Glushkova T, Mironov A, Krivkina E, Shabaev A, Senokosova E, Barbarash L. bFGF and SDF-1α Improve In Vivo Performance of VEGF-Incorporating Small-Diameter Vascular Grafts. Pharmaceuticals (Basel). 2021 Mar 28;14(4). doi: 10.3390/ph14040302. PMID: 33800631; PMCID: PMC8065794.
Copy Download .nbib Format: NLM
Thyroid disorders and pathospermia in the ART clinic patients.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology

Lisovskaya TV, Dubrovina OS, Treshchilov IM, Senturina LB, Sevostyanova OY, Mayasina EN, Buev YE, Salimov DF.
PMID: 34937506
Gynecol Endocrinol. 2021;37:4-7. doi: 10.1080/09513590.2021.2006439.

OBJECTIVE: Over the past decade, a decrease in the semen quality in men of reproductive age, along with an increase in the incidence of thyroid diseases among young patients have been clearly noticed. The study was designed to determine...

Cite
Lisovskaya TV, Dubrovina OS, Treshchilov IM, et al. Thyroid disorders and pathospermia in the ART clinic patients. Gynecol Endocrinol. 2021;37:4-7doi: 10.1080/09513590.2021.2006439.
Lisovskaya, T. V., Dubrovina, O. S., Treshchilov, I. M., Senturina, L. B., Sevostyanova, O. Y., Mayasina, E. N., Buev, Y. E., & Salimov, D. F. (2021). Thyroid disorders and pathospermia in the ART clinic patients. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 374-7. https://doi.org/10.1080/09513590.2021.2006439
Lisovskaya, T V, et al. "Thyroid disorders and pathospermia in the ART clinic patients." Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology vol. 37 (2021): 4-7. doi: https://doi.org/10.1080/09513590.2021.2006439
Lisovskaya TV, Dubrovina OS, Treshchilov IM, Senturina LB, Sevostyanova OY, Mayasina EN, Buev YE, Salimov DF. Thyroid disorders and pathospermia in the ART clinic patients. Gynecol Endocrinol. 2021;37:4-7. doi: 10.1080/09513590.2021.2006439. PMID: 34937506.
Copy Download .nbib Format: NLM
Modification of Glyceraldehyde-3-Phosphate Dehydrogenase with Nitric Oxide: Role in Signal Transduction and Development of Apoptosis.

Biomolecules

Muronetz VI, Medvedeva MV, Sevostyanova IA, Schmalhausen EV.
PMID: 34827652
Biomolecules. 2021 Nov 08;11(11). doi: 10.3390/biom11111656.

This review focuses on the consequences of GAPDH

Cite
Muronetz VI, Medvedeva MV, Sevostyanova IA, et al. Modification of Glyceraldehyde-3-Phosphate Dehydrogenase with Nitric Oxide: Role in Signal Transduction and Development of Apoptosis. Biomolecules. 2021;11(11)doi: 10.3390/biom11111656.
Muronetz, V. I., Medvedeva, M. V., Sevostyanova, I. A., & Schmalhausen, E. V. (2021). Modification of Glyceraldehyde-3-Phosphate Dehydrogenase with Nitric Oxide: Role in Signal Transduction and Development of Apoptosis. Biomolecules, 11(11), . https://doi.org/10.3390/biom11111656
Muronetz, Vladimir I, et al. "Modification of Glyceraldehyde-3-Phosphate Dehydrogenase with Nitric Oxide: Role in Signal Transduction and Development of Apoptosis." Biomolecules vol. 11,11 (2021). doi: https://doi.org/10.3390/biom11111656
Muronetz VI, Medvedeva MV, Sevostyanova IA, Schmalhausen EV. Modification of Glyceraldehyde-3-Phosphate Dehydrogenase with Nitric Oxide: Role in Signal Transduction and Development of Apoptosis. Biomolecules. 2021 Nov 08;11(11). doi: 10.3390/biom11111656. PMID: 34827652; PMCID: PMC8615796.
Copy Download .nbib Format: NLM
Modification of Glyceraldehyde-3-Phosphate Dehydrogenase with Nitric Oxide: Role in Signal Transduction and Development of Apoptosis.

Biomolecules

Muronetz VI, Medvedeva MV, Sevostyanova IA, Schmalhausen EV.
PMID: 34827652
Biomolecules. 2021 Nov 08;11(11). doi: 10.3390/biom11111656.

This review focuses on the consequences of GAPDH

Cite
Muronetz VI, Medvedeva MV, Sevostyanova IA, et al. Modification of Glyceraldehyde-3-Phosphate Dehydrogenase with Nitric Oxide: Role in Signal Transduction and Development of Apoptosis. Biomolecules. 2021;11(11)doi: 10.3390/biom11111656.
Muronetz, V. I., Medvedeva, M. V., Sevostyanova, I. A., & Schmalhausen, E. V. (2021). Modification of Glyceraldehyde-3-Phosphate Dehydrogenase with Nitric Oxide: Role in Signal Transduction and Development of Apoptosis. Biomolecules, 11(11), . https://doi.org/10.3390/biom11111656
Muronetz, Vladimir I, et al. "Modification of Glyceraldehyde-3-Phosphate Dehydrogenase with Nitric Oxide: Role in Signal Transduction and Development of Apoptosis." Biomolecules vol. 11,11 (2021). doi: https://doi.org/10.3390/biom11111656
Muronetz VI, Medvedeva MV, Sevostyanova IA, Schmalhausen EV. Modification of Glyceraldehyde-3-Phosphate Dehydrogenase with Nitric Oxide: Role in Signal Transduction and Development of Apoptosis. Biomolecules. 2021 Nov 08;11(11). doi: 10.3390/biom11111656. PMID: 34827652; PMCID: PMC8615796.
Copy Download .nbib Format: NLM
Vascular Endothelial Growth Factor Improves Physico-Mechanical Properties and Enhances Endothelialization of Poly(3-hydroxybutyrate-co-3-hydroxyvalerate)/Poly(ε-caprolactone) Small-Diameter Vascular Grafts In vivo.

Frontiers in pharmacology

Antonova LV, Sevostyanova VV, Kutikhin AG, Mironov AV, Krivkina EO, Shabaev AR, Matveeva VG, Velikanova EA, Sergeeva EA, Burago AY, Vasyukov GY, Glushkova TV, Kudryavtseva YA, Barbarash OL, Barbarash LS.
PMID: 27524968
Front Pharmacol. 2016 Jul 29;7:230. doi: 10.3389/fphar.2016.00230. eCollection 2016.

The combination of a natural polymer poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) and a synthetic hydrophobic polymer poly(ε-caprolactone) (PCL) is promising for the preparation of biodegradable and biocompatible small-diameter vascular grafts for bypass surgery. However, physico-mechanical properties and endothelialization rate of PHBV/PCL grafts...

Cite
Antonova LV, Sevostyanova VV, Kutikhin AG, et al. Vascular Endothelial Growth Factor Improves Physico-Mechanical Properties and Enhances Endothelialization of Poly(3-hydroxybutyrate-co-3-hydroxyvalerate)/Poly(ε-caprolactone) Small-Diameter Vascular Grafts In vivo. Front Pharmacol. 2016;7:230doi: 10.3389/fphar.2016.00230.
Antonova, L. V., Sevostyanova, V. V., Kutikhin, A. G., Mironov, A. V., Krivkina, E. O., Shabaev, A. R., Matveeva, V. G., Velikanova, E. A., Sergeeva, E. A., Burago, A. Y., Vasyukov, G. Y., Glushkova, T. V., Kudryavtseva, Y. A., Barbarash, O. L., & Barbarash, L. S. (2016). Vascular Endothelial Growth Factor Improves Physico-Mechanical Properties and Enhances Endothelialization of Poly(3-hydroxybutyrate-co-3-hydroxyvalerate)/Poly(ε-caprolactone) Small-Diameter Vascular Grafts In vivo. Frontiers in pharmacology, 7230. https://doi.org/10.3389/fphar.2016.00230
Antonova, Larisa V, et al. "Vascular Endothelial Growth Factor Improves Physico-Mechanical Properties and Enhances Endothelialization of Poly(3-hydroxybutyrate-co-3-hydroxyvalerate)/Poly(ε-caprolactone) Small-Diameter Vascular Grafts In vivo." Frontiers in pharmacology vol. 7 (2016): 230. doi: https://doi.org/10.3389/fphar.2016.00230
Antonova LV, Sevostyanova VV, Kutikhin AG, Mironov AV, Krivkina EO, Shabaev AR, Matveeva VG, Velikanova EA, Sergeeva EA, Burago AY, Vasyukov GY, Glushkova TV, Kudryavtseva YA, Barbarash OL, Barbarash LS. Vascular Endothelial Growth Factor Improves Physico-Mechanical Properties and Enhances Endothelialization of Poly(3-hydroxybutyrate-co-3-hydroxyvalerate)/Poly(ε-caprolactone) Small-Diameter Vascular Grafts In vivo. Front Pharmacol. 2016 Jul 29;7:230. doi: 10.3389/fphar.2016.00230. eCollection 2016. PMID: 27524968; PMCID: PMC4965475.
Copy Download .nbib Format: NLM
[The software for jam-resistant sampling of analog EEG records on paper].

Meditsinskaia tekhnika

Ivanov KO, Sevastyanov VV, Furman YA.
PMID: 25980217
Med Tekh. 2015 Jan-Feb;(1):30-2.

No abstract available.

Cite
Ivanov KO, Sevastyanov VV, Furman YA. [The software for jam-resistant sampling of analog EEG records on paper]. Med Tekh. 2015;(1):30-2
Ivanov, K. O., Sevastyanov, V. V., & Furman, Y. A. (2015). [The software for jam-resistant sampling of analog EEG records on paper]. Meditsinskaia tekhnika, (1), 30-2.
Ivanov, K O, et al. "[The software for jam-resistant sampling of analog EEG records on paper]." Meditsinskaia tekhnika vol. ,1 (2015): 30-2.
Ivanov KO, Sevastyanov VV, Furman YA. [The software for jam-resistant sampling of analog EEG records on paper]. Med Tekh. 2015 Jan-Feb;(1):30-2. Russian. PMID: 25980217.
Copy Download .nbib Format: NLM
Biodegradable Patches for Arterial Reconstruction Modified with RGD Peptides: Results of an Experimental Study.

ACS omega

Sevostianova VV, Antonova LV, Mironov AV, Yuzhalin AE, Silnikov VN, Glushkova TV, Godovikova TS, Krivkina EO, Bolbasov E, Akentyeva TN, Khanova MY, Matveeva VG, Velikanova EA, Tarasov RS, Barbarash LS.
PMID: 32905385
ACS Omega. 2020 Aug 19;5(34):21700-21711. doi: 10.1021/acsomega.0c02593. eCollection 2020 Sep 01.

Modification by Arg-Gly-Asp (RGD) peptides is a promising approach to improve the biocompatibility of biodegradable vascular patches for arteriotomy. In this study, we evaluated the performance of vascular patches electrospun using a blend of polycaprolactone (PCL) and polyhydroxybutyrate/valerate (PHBV)...

Cite
Sevostianova VV, Antonova LV, Mironov AV, et al. Biodegradable Patches for Arterial Reconstruction Modified with RGD Peptides: Results of an Experimental Study. ACS Omega. 2020;5(34):21700-21711doi: 10.1021/acsomega.0c02593.
Sevostianova, V. V., Antonova, L. V., Mironov, A. V., Yuzhalin, A. E., Silnikov, V. N., Glushkova, T. V., Godovikova, T. S., Krivkina, E. O., Bolbasov, E., Akentyeva, T. N., Khanova, M. Y., Matveeva, V. G., Velikanova, E. A., Tarasov, R. S., & Barbarash, L. S. (2020). Biodegradable Patches for Arterial Reconstruction Modified with RGD Peptides: Results of an Experimental Study. ACS omega, 5(34), 21700-21711. https://doi.org/10.1021/acsomega.0c02593
Sevostianova, Viktoriia V, et al. "Biodegradable Patches for Arterial Reconstruction Modified with RGD Peptides: Results of an Experimental Study." ACS omega vol. 5,34 (2020): 21700-21711. doi: https://doi.org/10.1021/acsomega.0c02593
Sevostianova VV, Antonova LV, Mironov AV, Yuzhalin AE, Silnikov VN, Glushkova TV, Godovikova TS, Krivkina EO, Bolbasov E, Akentyeva TN, Khanova MY, Matveeva VG, Velikanova EA, Tarasov RS, Barbarash LS. Biodegradable Patches for Arterial Reconstruction Modified with RGD Peptides: Results of an Experimental Study. ACS Omega. 2020 Aug 19;5(34):21700-21711. doi: 10.1021/acsomega.0c02593. eCollection 2020 Sep 01. PMID: 32905385; PMCID: PMC7469394.
Copy Download .nbib Format: NLM
Biocompatibility of Small-Diameter Vascular Grafts in Different Modes of RGD Modification.

Polymers

Antonova LV, Silnikov VN, Sevostyanova VV, Yuzhalin AE, Koroleva LS, Velikanova EA, Mironov AV, Godovikova TS, Kutikhin AG, Glushkova TV, Serpokrylova IY, Senokosova EA, Matveeva VG, Khanova MY, Akentyeva TN, Krivkina EO, Kudryavtseva YA, Barbarash LS.
PMID: 30960158
Polymers (Basel). 2019 Jan 18;11(1). doi: 10.3390/polym11010174.

Modification with Arg-Gly-Asp (RGD) peptides is a promising approach to improve biocompatibility of small-calibre vascular grafts but it is unknown how different RGD sequence composition impacts graft performance. Here we manufactured 1.5 mm poly(3-hydroxybutyrate-

Cite
Antonova LV, Silnikov VN, Sevostyanova VV, et al. Biocompatibility of Small-Diameter Vascular Grafts in Different Modes of RGD Modification. Polymers (Basel). 2019;11(1)doi: 10.3390/polym11010174.
Antonova, L. V., Silnikov, V. N., Sevostyanova, V. V., Yuzhalin, A. E., Koroleva, L. S., Velikanova, E. A., Mironov, A. V., Godovikova, T. S., Kutikhin, A. G., Glushkova, T. V., Serpokrylova, I. Y., Senokosova, E. A., Matveeva, V. G., Khanova, M. Y., Akentyeva, T. N., Krivkina, E. O., Kudryavtseva, Y. A., & Barbarash, L. S. (2019). Biocompatibility of Small-Diameter Vascular Grafts in Different Modes of RGD Modification. Polymers, 11(1), . https://doi.org/10.3390/polym11010174
Antonova, Larisa V, et al. "Biocompatibility of Small-Diameter Vascular Grafts in Different Modes of RGD Modification." Polymers vol. 11,1 (2019). doi: https://doi.org/10.3390/polym11010174
Antonova LV, Silnikov VN, Sevostyanova VV, Yuzhalin AE, Koroleva LS, Velikanova EA, Mironov AV, Godovikova TS, Kutikhin AG, Glushkova TV, Serpokrylova IY, Senokosova EA, Matveeva VG, Khanova MY, Akentyeva TN, Krivkina EO, Kudryavtseva YA, Barbarash LS. Biocompatibility of Small-Diameter Vascular Grafts in Different Modes of RGD Modification. Polymers (Basel). 2019 Jan 18;11(1). doi: 10.3390/polym11010174. PMID: 30960158; PMCID: PMC6401695.
Copy Download .nbib Format: NLM
Tissue-Engineered Carotid Artery Interposition Grafts Demonstrate High Primary Patency and Promote Vascular Tissue Regeneration in the Ovine Model.

Polymers

Antonova LV, Krivkina EO, Sevostianova VV, Mironov AV, Rezvova MA, Shabaev AR, Tkachenko VO, Krutitskiy SS, Khanova MY, Sergeeva TY, Matveeva VG, Glushkova TV, Kutikhin AG, Mukhamadiyarov RA, Deeva NS, Akentieva TN, Sinitsky MY, Velikanova EA, Barbarash LS.
PMID: 34451177
Polymers (Basel). 2021 Aug 08;13(16). doi: 10.3390/polym13162637.

Tissue-engineered vascular graft for the reconstruction of small arteries is still an unmet clinical need, despite the fact that a number of promising prototypes have entered preclinical development. Here we test Poly(3-hydroxybutyrate-co-3-hydroxyvalerate)Poly(ε-caprolactone) 4-mm-diameter vascular grafts equipped with vascular endothelial...

Cite
Antonova LV, Krivkina EO, Sevostianova VV, et al. Tissue-Engineered Carotid Artery Interposition Grafts Demonstrate High Primary Patency and Promote Vascular Tissue Regeneration in the Ovine Model. Polymers (Basel). 2021;13(16)doi: 10.3390/polym13162637.
Antonova, L. V., Krivkina, E. O., Sevostianova, V. V., Mironov, A. V., Rezvova, M. A., Shabaev, A. R., Tkachenko, V. O., Krutitskiy, S. S., Khanova, M. Y., Sergeeva, T. Y., Matveeva, V. G., Glushkova, T. V., Kutikhin, A. G., Mukhamadiyarov, R. A., Deeva, N. S., Akentieva, T. N., Sinitsky, M. Y., Velikanova, E. A., & Barbarash, L. S. (2021). Tissue-Engineered Carotid Artery Interposition Grafts Demonstrate High Primary Patency and Promote Vascular Tissue Regeneration in the Ovine Model. Polymers, 13(16), . https://doi.org/10.3390/polym13162637
Antonova, Larisa V, et al. "Tissue-Engineered Carotid Artery Interposition Grafts Demonstrate High Primary Patency and Promote Vascular Tissue Regeneration in the Ovine Model." Polymers vol. 13,16 (2021). doi: https://doi.org/10.3390/polym13162637
Antonova LV, Krivkina EO, Sevostianova VV, Mironov AV, Rezvova MA, Shabaev AR, Tkachenko VO, Krutitskiy SS, Khanova MY, Sergeeva TY, Matveeva VG, Glushkova TV, Kutikhin AG, Mukhamadiyarov RA, Deeva NS, Akentieva TN, Sinitsky MY, Velikanova EA, Barbarash LS. Tissue-Engineered Carotid Artery Interposition Grafts Demonstrate High Primary Patency and Promote Vascular Tissue Regeneration in the Ovine Model. Polymers (Basel). 2021 Aug 08;13(16). doi: 10.3390/polym13162637. PMID: 34451177; PMCID: PMC8400235.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 12 entries